Wells Fargo & Company Bristol Myers Squibb CO Cont V Transaction History

Wells Fargo & Company

  • $407 Billion
  • Q2 2024

A detailed history of Wells Fargo & Company transactions in Bristol Myers Squibb CO Cont V stock. As of the latest transaction made, Wells Fargo & Company holds 28 shares of CELGRT stock, worth $0. This represents 0.0% of its overall portfolio holdings.

Number of Shares
28
Previous 28 -0.0%
Holding current value
$0
Previous $0 NaN%
% of portfolio
0.0%
Previous 0.0%

Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 10, 2024
SELL
N/A
-3 Reduced 9.68%
28 $0
Q4 2023

Feb 09, 2024
BUY
N/A
3 Added 10.71%
31 $0
Q2 2023

Aug 15, 2023
BUY
N/A
1 Added 3.7%
28 $0
Q1 2023

May 12, 2023
SELL
N/A
-1 Reduced 3.57%
27 $0
Q2 2022

Aug 12, 2022
BUY
N/A
18 Added 180.0%
28 $0
Q3 2021

Nov 15, 2021
SELL
N/A
-252 Reduced 96.18%
10 $0
Q1 2020

May 14, 2020
BUY
N/A
262 New
262 $0

Others Institutions Holding CELGRT

# of Institutions
19
Shares Held
502K
Call Options Held
0
Put Options Held
0
View Full List

About BRISTOL MYERS SQUIBB CO CONT V

CELGRT Quotes by TradingView
  • Ticker CELGRT
More about CELGRT
Track This Portfolio

Track Wells Fargo & Company Portfolio

Follow Wells Fargo & Company and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

News

Stay updated on Wells Fargo & Company with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email